D.E. Shaw & Co’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-2,229
| Closed | -$38K | – | 2919 |
|
|
2015
Q4 | $38K | Sell |
2,229
-7,545
| -77% | -$129K | ﹤0.01% | 2582 |
|
|
2015
Q3 | $206K | Sell |
9,774
-14,191
| -59% | -$299K | ﹤0.01% | 2340 |
|
|
2015
Q2 | $1.19M | Sell |
23,965
-58,291
| -71% | -$2.88M | ﹤0.01% | 1745 |
|
|
2015
Q1 | $6.44M | Buy |
82,256
+8,574
| +12% | +$671K | 0.01% | 847 |
|
|
2014
Q4 | $4.47M | Sell |
73,682
-28,054
| -28% | -$1.7M | 0.01% | 985 |
|
|
2014
Q3 | $4.33M | Buy |
101,736
+16,505
| +19% | +$703K | 0.01% | 922 |
|
|
2014
Q2 | $5.27M | Buy |
85,231
+13,122
| +18% | +$811K | 0.01% | 886 |
|
|
2014
Q1 | $4.69M | Sell |
72,109
-82,709
| -53% | -$5.38M | 0.01% | 909 |
|
|
2013
Q4 | $8.72M | Buy |
154,818
+14,927
| +11% | +$840K | 0.01% | 673 |
|
|
2013
Q3 | $8.59M | Buy |
139,891
+463
| +0.3% | +$28.4K | 0.01% | 619 |
|
|
2013
Q2 | $8.16M | Buy |
+139,428
| New | +$8.16M | 0.02% | 620 |
|